404 related articles for article (PubMed ID: 16827885)
1. Unusual evolution of Waldenström's macroglobulinemia into osteolytic myeloma.
Jondeau K; Alterescu R; Franc B; Davi F; Massé JM; Boukour S; Le Parc JM; Cramer EM
Eur J Haematol; 2006 Jul; 77(1):74-9. PubMed ID: 16827885
[TBL] [Abstract][Full Text] [Related]
2. Unusual inclusions in plasmacytoid cells. Their occurrence in a patient with Waldenström's macroglobulinemia.
Ricci A; Monahan RA; Paradise C; Robinson S; Dvorak AM
Arch Pathol Lab Med; 1982 Sep; 106(9):452-7. PubMed ID: 6287959
[TBL] [Abstract][Full Text] [Related]
3. Developing diagnostic criteria in Waldenstrom's macroglobulinemia.
Owen RG
Semin Oncol; 2003 Apr; 30(2):196-200. PubMed ID: 12720135
[TBL] [Abstract][Full Text] [Related]
4. 14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia.
Avet-Loiseau H; Garand R; Lodé L; Robillard N; Bataille R
Semin Oncol; 2003 Apr; 30(2):153-5. PubMed ID: 12720126
[TBL] [Abstract][Full Text] [Related]
5. IgM myeloma: a report of four cases.
Dierlamm T; Laack E; Dierlamm J; Fiedler W; Hossfeld DK
Ann Hematol; 2002 Mar; 81(3):136-9. PubMed ID: 11904738
[TBL] [Abstract][Full Text] [Related]
6. Smouldering Waldenstrom's macroglobulinemia: factors predicting evolution to symptomatic disease.
Cesana C; Miqueleiz S; Bernuzzi P; Tresoldi E; Rossi V; D'avanzo G; Filippini D; Morra E
Semin Oncol; 2003 Apr; 30(2):231-5. PubMed ID: 12720142
[TBL] [Abstract][Full Text] [Related]
7. [IgM myeloma. Apropos of a case].
Heron JF; Guaydier G; Loyau G; Laniece M; Mandart JC; Borel B; L'Hirondel JL; Dumas M; Foucault JP
Sem Hop; 1976 Dec; 52(44):2549-52. PubMed ID: 188198
[No Abstract] [Full Text] [Related]
8. [Hypercalcemia complicating Waldenström's disease: a manifestation of Richter's syndrome].
Casassus P; Vannetzel JM; Tricot G; D'Agay MF; Lortholary P; Desrues J; Pariente P
Ann Med Interne (Paris); 1983; 134(2):130-3. PubMed ID: 6410954
[TBL] [Abstract][Full Text] [Related]
9. Concomitant Waldenstrom macroglobulinemia and IgA plasmablastic myeloma in a patient with untreated IgM paraproteinemia: sequential development of biclonal B-cell neoplasms over a 10-year period in a single individual.
Wang E; Kulbacki E; Stoecker M
Hum Pathol; 2012 Jul; 43(7):1135-41. PubMed ID: 22404949
[TBL] [Abstract][Full Text] [Related]
10. [IgM myeloma].
Roujeau JC; Bisson M; Segond P; Massias P
Sem Hop; 1976 Nov; 52(40):2277-82. PubMed ID: 188179
[TBL] [Abstract][Full Text] [Related]
11. Malignant transformation in IgM monoclonal gammopathy of undetermined significance.
Montoto S; Rozman M; Rosiñol L; Nadal E; Giné E; Aymerich M; Ferrer A; Esteve J; Bosch F; López-Guillermo A; Bladé J; Montserrat E
Semin Oncol; 2003 Apr; 30(2):178-81. PubMed ID: 12720132
[TBL] [Abstract][Full Text] [Related]
12. Electron microscopic observation of inclusion bodies in plasma cells of multiple myeloma and Waldenström's macroglobulinemia.
Oikawa K
Tohoku J Exp Med; 1975 Nov; 117(3):257-81. PubMed ID: 173043
[TBL] [Abstract][Full Text] [Related]
13. Waldenström's macroglobulinemia: a clinicopathologic study of 22 cases.
Andriko JA; Aguilera NS; Chu WS; Nandedkar MA; Cotelingam JD
Cancer; 1997 Nov; 80(10):1926-35. PubMed ID: 9366295
[TBL] [Abstract][Full Text] [Related]
14. IL-1beta expression in IgM monoclonal gammopathy and its relationship to multiple myeloma.
Donovan KA; Lacy MQ; Gertz MA; Lust JA
Leukemia; 2002 Mar; 16(3):382-5. PubMed ID: 11896542
[TBL] [Abstract][Full Text] [Related]
15. [Cutaneous Waldenström's macroglobulinemia].
Mantoux F; Castanet J; Perrin C; Fuzibet JG; Lacour JP; Ortonne JP
Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):53-5. PubMed ID: 11937931
[TBL] [Abstract][Full Text] [Related]
16. Transformation and progression of Waldenström's macroglobulinemia following cladribine therapy in two cases: natural evolution or iatrogenic causation?
Ling S; Joshua DE; Gibson J; Young G; Iland H; Watson G; Ho PJ
Am J Hematol; 2006 Feb; 81(2):110-4. PubMed ID: 16432856
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis in Waldenstrom's macroglobulinemia.
Rajkumar SV; Hayman S; Greipp PR
Semin Oncol; 2003 Apr; 30(2):262-4. PubMed ID: 12720149
[TBL] [Abstract][Full Text] [Related]
18. [Morphologic manifestations of Waldenström's disease].
Diebold J; Reynes M; Kalifat R; Tricot G
Sem Hop; 1975 Dec; 51(48):2927-34. PubMed ID: 175504
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals.
Gutiérrez NC; Ocio EM; de Las Rivas J; Maiso P; Delgado M; Fermiñán E; Arcos MJ; Sánchez ML; Hernández JM; San Miguel JF
Leukemia; 2007 Mar; 21(3):541-9. PubMed ID: 17252022
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequences.
Kriangkum J; Taylor BJ; Treon SP; Mant MJ; Reiman T; Belch AR; Pilarski LM
Clin Cancer Res; 2007 Apr; 13(7):2005-13. PubMed ID: 17404080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]